The Impact of CRISPR-Cas9 on Age-related Disorders: From Pathology to Therapy.

Caobi, Allen; Dutta, Rajib Kumar; Garbinski, Luis D; Esteban-Lopez, Maria; Ceyhan, Yasemin; Andre, Mickensone; Manevski, Marko; Ojha, Chet Raj; Lapierre, Jessica; Tiwari, Sneham; Parira, Tiyash; El-Hage, Nazira

Caobi, Allen; Dutta, Rajib Kumar; Garbinski, Luis D; Esteban-Lopez, Maria; Ceyhan, Yasemin; Andre, Mickensone; Manevski, Marko; Ojha, Chet Raj; Lapierre, Jessica; Tiwari, Sneham; Parira, Tiyash; El-Hage, Nazira.

Afiliação

Caobi A; 1Departments of Immunology and Nano-medicine.
Dutta RK; 1Departments of Immunology and Nano-medicine.
Garbinski LD; 3Cell Biology and Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA.
Esteban-Lopez M; 2Human and Molecular Genetics and.
Ceyhan Y; 2Human and Molecular Genetics and.
Andre M; 1Departments of Immunology and Nano-medicine.
Manevski M; 1Departments of Immunology and Nano-medicine.
Ojha CR; 1Departments of Immunology and Nano-medicine.
Lapierre J; 1Departments of Immunology and Nano-medicine.
Tiwari S; 1Departments of Immunology and Nano-medicine.
Parira T; 1Departments of Immunology and Nano-medicine.
El-Hage N; 1Departments of Immunology and Nano-medicine.

Aging Dis ; 11(4): 895-915, 2020 Jul.

Article em En | MEDLINE | ID: mdl-32765953

Palavras-chave

CRISPR-Cas9; aging; alternative medicine; cancer; gene-editing; neurodegeneration

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Aging Dis Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google